Urine Biomarker Assessment of Infant Adherence to Isoniazid Prophylaxis

Pediatr Infect Dis J. 2021 Jan;40(1):e43-e45. doi: 10.1097/INF.0000000000002936.

Abstract

We assessed adherence in an infant tuberculosis prevention trial in Kenya with a urine isoniazid metabolite-detecting dipstick. Ninety-seven infants had 155 assays performed; 77 (49.7%) were found to be positive despite caregiver-reported adherence. Positive assays were associated with maternal secondary education, HIV suppression and no reported missed doses in past 3 days, suggesting caregiver education and self-medication use influenced infant adherence.

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Biomarkers / urine
  • Cohort Studies
  • Female
  • HIV Infections
  • Humans
  • Infant
  • Isoniazid / therapeutic use
  • Isoniazid / urine*
  • Kenya
  • Male
  • Medication Adherence*
  • Randomized Controlled Trials as Topic
  • Tuberculosis* / drug therapy
  • Tuberculosis* / prevention & control

Substances

  • Antitubercular Agents
  • Biomarkers
  • Isoniazid